Iovance infuses USD 75 M to boost Cancer therapy Iovance Biotherapeutics is all set to build a 136,000-square-foot facility in Philadelphia to develop cancer therapies using its tumour-infiltrating...
Stem cells can regenerate heart Researchers at the Icahn School of Medicine, U.S.A in their recent study revealed that stem cells extracted from placenta also known as Cdx2 cells might be able to regenerate heart cells after the heart attack. From the beginning, it has been thought that Cdx2 cells could only ge...
Find MoreMerck decides to acquire Peloton Therapeutics, fortifying Oncology pipeline Merck is ready to buy Peloton Therapeutics for USD 1.1 million. The companies have entered into a definitive agreement which will give Merck rights over an oral HIF-2α inhibitor- PT2977, which is Peloton’s lead candidate for the treatme...
Find MoreFDA approves Fragmin- an anticoagulant for children The FDA today approved Fragmin for the treatment of blood clots. Pfizer’s candidate Fragmin which was earlier approved for the treatment of only adults suffering from a fatal disease called VTE, which can include deep vein thrombosis (blood clot in the d...
Find MoreGinkgo announces to buy Warp Drive Bio’s genome mining platform Ginkgo Bioworks has announced to acquire the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines. The acquisition will give Gingko access to Warp Drive Bio's genome mining team, technology, and database. This coll...
Find MoreFDA gives green signal to HealthPNX Zebra Medical Vision- an Israel-based developer recently has received FDA’s approval to use Artificial Intelligence to scan and analyze chest X-rays. It will help identify pneumothorax which is the buildup of air inside the pleural cavity, caused by injury either to the lung o...
Find MoreAstraZeneca-Daiichi breast cancer treatment scored promising results The breast cancer drug trastuzumab deruxtecan developed by AstraZeneca and Daiichi Sankyo showed positive results in a metastatic breast cancer trial. AstraZeneca remunerated Daiichi Sankyo USD 1.35 billion upfront and guaranteed up to USD 6.9 ...
Find MoreRoche's takes a step- forward to treat Huntington's disease A new drug co-developed by Roche and Ionis Pharmaceuticals can be a potential candidate to treat Huntington's disease. RG6042 which is an antisense oligonucleotide is able to successfully lower down the production of a toxic protein that results in dysf...
Find MoreEISAI now solely responsible for lemborexant Eisai today announced that its U.S. subsidiary has bought out Purdue Pharma L.P.’s rights in the worldwide collaboration for the development and commercialization of lemborexant, an investigational sleep-wake regulation agent being studied for the treatment of multip...
Find MoreA Praluent boost for Sanofi, and Regeneron The U.S. FDA has given its nod to Praluent (alirocumab) to be used for reducing the risk of heart attack, stroke, and unstable angina requiring hospitalization in adults with established cardiovascular (CV) disease. Praluent is an injectable prescription medicine co-dev...
Find MoreMedical device manufacturing and development is a high-capital demanding endeavor and therefore the .....
Find MoreUS Cancer Statistics show that more than half a million suffer from this disease, which is the secon.....
Find MoreHealthcare Performance Improvement provides proven methods for sustaining and building a culture of .....
Find MoreAnorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in.....
Find MoreFibrodysplasia Ossificans Progressiva (FOP) is a rare disorder that results in gradual ossification .....
Find MoreAnorexia Nervosa (AN) is a psychological condition that is characterized by an abnormally low weight.....
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.